Drug Database
Back to search

Japan· JP-3929007F2025

酢酸亜鉛水和物

A medicinal product containing 酢酸亜鉛水和物, registered in Japan by ノーベルファーマ, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalised酢酸亜鉛水和物ATC—REGISTER NO.JP-3929007F2025PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about 酢酸亜鉛水和物Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)
Active substance
酢酸亜鉛水和物
Manufacturer
ノーベルファーマ
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

酢酸亜鉛水和物 in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 酢酸亜鉛水和物 products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Labisan, Zink Aguettant
  • Belgium · Unguentum, Zinc Aguettant
  • Germany · Biolectra, Cefazink
  • Denmark · Zipzoc
  • Spain · Pasta Lassar Imba
  • Finland · Zipzoc
  • France · Effizinc, Oligosol
  • United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
  • Greece · Zincalto, Zinctin
  • Ireland · Caldease, Zinc Ovelle
  • Iceland · Wilzin
  • Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
  • Liechtenstein · Wilzin
  • Luxembourg · Cefazink, Oligosol
  • Latvia · Cinka Rff
  • Netherlands · Daro Zinkzalf, Zinkolie
  • Norway · Wilzin
  • Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
  • Portugal · Halibut, Lassadermil
  • Sweden · Zipzoc
  • Slovakia · Tekutý Púder

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb4b5cb1-56d2-4a8a-8cf4-05b4b124cc12
GET /v1/drugs/bb4b5cb1-56d2-4a8a-8cf4-05b4b124cc12?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3929007F2025",
  "category": "内用薬",
  "price_yen": 321.6,
  "generic_name": "酢酸亜鉛水和物",
  "product_name_jp": null,
  "therapeutic_class": "3929",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about 酢酸亜鉛水和物.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console